Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 14,938 $ 267,401 $ (40,984) $ 241,355
Balance (in Shares) at Dec. 31, 2020 7,469,125        
Issuance of common stock for cash $ 1,271 1,207,655 1,208,926
Issuance of common stock for cash (in Shares) 635,594        
Net loss (549,609) (549,609)
Balance at Mar. 31, 2021 $ 16,209 1,475,056 (590,593) 900,672
Balance (in Shares) at Mar. 31, 2021 8,104,719        
Balance at Dec. 31, 2021 $ 17,684 53,627,883 (10,561) (2,214,505) 51,420,501
Balance (in Shares) at Dec. 31, 2021 23,008,371        
Stock-based compensation expense 135,630 135,630
Foreign currency translation (4,513) (4,513)
Net loss (1,574,240) (1,574,240)
Balance at Mar. 31, 2022 $ 17,684 $ 53,763,513 $ (15,074) $ (3,788,745) $ 49,977,378
Balance (in Shares) at Mar. 31, 2022 23,008,371